Last update Jan. 30, 2021
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
سالبوتامول is Albuterol in Arabic.Is written in other languages:
سالبوتامول is also known as
سالبوتامول belongs to these groups or families:
Main tradenames from several countries containing سالبوتامول in its composition:
|Oral Bioavail.||50 (inhala: 10)||%|
|Tmax||0.2 - 0.4||hours|
|T½||2.7 - 5||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Short-acting beta-adrenergic bronchodilator, similar in characteristics to Terbutaline.
Indicated in the treatment of asthma.
Administration preferably inhaled (also oral or intravenous).
Its large volume of distribution and poor absorption after inhaled administration make it highly unlikely that significant quantities will pass into milk.
Its low oral bioavailability would make it difficult its passage to the infant’s plasma through breast milk.
Inhaled preparations are preferred since they are absorbed less than 10 %.
Several medical societies, experts authors and expert consensus consider the use of inhaled bronchodilators to be safe during breastfeeding (Hale, Lactmed, Amir 2011, National Asthma 2004, Nelson 2001, Ellsworth 1994).
List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).